Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK0826 vs Meropenem in Complicated Urinary Tract Infection
NCT00771316Phase 3Terminated
- Sponsor
- Merck & Co.
- Start
- Dec 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules
01
Overview
Phase 3, randomised trial of ertapenem in complicated urinary tract infection (cUTI) and acute pyelonephritis (2 arms), sponsored by Merck & Co. Primary endpoints: Overall Microbiological Response, Clinical Response at DCIV and 1 more. Started Dec 2008; status: terminated.
02
Drugs
ertapenem
03
Conditions
complicated urinary tract infection (cUTI)acute pyelonephritis
Beyond the preview
Go deeper on NCT00771316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00771316.